Improve Clinical Outcomes by Testing for All Actionable Biomarkers

Precision oncology may lead to an improvement in clinical outcomes for certain patients. There are several important factors when considering treatment options, such as efficacy and safety data, evidence-based guidelines, staging, comorbidities, patient preference, and a patient’s biomarker status. This program reinforces that testing for all actionable biomarkers is an important factor to patient care and may improve clinical outcomes for some patients.